Peptide Stack Analyzer Tool Peptide Directory Peptide Discussion Forum Peptide Tools: Stacker & Calculators Trusted Vendors + Vendor Red Flags
Labels

CJC-1295 NO DAC Dosage, Protocol, and GH Optimization Guide (Mod GRF 1–29)

CJC-1295 NO DAC (Mod GRF 1–29)

CJC-1295 NO DAC (Modified GRF 1–29) is a short-acting GHRH analog studied for its ability to stimulate growth hormone release through GHRH receptor signaling. Compared with long-acting DAC versions, it is designed to provide shorter-duration GH pathway activation.

How CJC-1295 NO DAC Works

GHRH Signal → Pituitary Activation → GH Pulse ↑ → IGF-1 ↑ → Recovery + Fat Loss ↑

CJC-1295 NO DAC binds to GHRH receptors in the pituitary, triggering natural GH pulses. Its short half-life (~30 minutes) mimics the body’s normal secretion pattern, making it ideal for physiologic hormone optimization.

Short-acting GHRH analog designed for pulsatile GH release.
Different from CJC-1295 DAC, which has a much longer half-life.
Often discussed with GHRPs like Ipamorelin for stronger GH pulse signaling.
Best used with consistent timing, usually fasted before bed.
CJC-1295 NO DAC Research Protocol
5 mg vial + 3.0 mL BAC Water → 1 unit = 16.7 mcg → Short GH Pulse Support
Standard Setup
Vial 5 mg
Water 3.0 mL bacteriostatic water
Concentration 1.67 mg/mL
Conversion 1 unit = 16.7 mcg
Weeks 1–2
Start Phase
Dose100 mcg
Units6 units
Volume0.06 mL
Weeks 3–4
Build Phase
Dose150 mcg
Units9 units
Volume0.09 mL
Weeks 5–6
Peak Phase
Dose200 mcg
Units12 units
Volume0.12 mL
Weeks 7–12
Maintain Phase
Dose250–300 mcg
Units15–18 units
Volume0.15–0.18 mL
Protocol Details
FrequencyOnce daily
Advanced Frequency2x daily
TimingBedtime, fasted ≥2 hours
Cycle Length8–12 weeks
Optional ExtensionUp to 16 weeks
Simple structure
CJC-1295 NO DAC is built around short, natural GH pulse support. Because it is short-acting, consistent timing matters more than with DAC versions.
Clinical vs Real-World Use
Key Differences
Short half-life requires consistent timing
Pulsatile GH release mimics natural physiology
Often stacked with GHRPs like Ipamorelin in research-style protocols
More timing-sensitive than long-acting DAC versions
Simple comparison:
NO DAC is better for short pulse-style GH signaling. DAC is better for convenience and smoother long-acting exposure.
How to Use CJC-1295 NO DAC (Timing & Injection)
Injection TypeSubcutaneous
TimingBefore bed
Fasted StateFasted ≥2 hours
Advanced OptionSplit AM + PM dosing
When & Where to Inject
Subcutaneous injection
Abdomen, thigh, or upper arm
Administer before bed while fasted
Optional split AM + PM dosing for advanced users
Rotate injection sites regularly
Timing Notes
Bedtime dosing is commonly used to align with nighttime recovery.
Fasted timing is preferred because food may blunt GH signaling.
Because NO DAC is short-acting, timing matters more than with CJC-1295 DAC.
Reconstitution & Dosing (5 mg Vial)
Vial5 mg
Water3.0 mL bacteriostatic
Concentration1.67 mg/mL
Conversion1 unit = 16.7 mcg
Dose Reference
6 units ≈ 100 mcg
9 units ≈ 150 mcg
12 units ≈ 200 mcg
15 units ≈ 250 mcg
18 units ≈ 300 mcg
Reconstitution Steps
Draw 3.0 mL bacteriostatic water
Inject slowly down vial wall
Gently swirl, do not shake
Allow powder to fully dissolve
Label with mix date
Refrigerate immediately
Storage & Shelf Life
Storage & Shelf Life
Lyophilized (Unmixed)
Short-term: refrigerate at 2–8°C
Long-term: freeze at −20°C / −4°F
Refrigerated shelf life: ~12–24 months when sealed and dry
Frozen shelf life: ~2–3 years when stored properly
Keep sealed, dry, and protected from light
Avoid moisture, heat, sunlight, and repeated temperature changes
Do not repeatedly freeze and thaw the same vial
Reconstituted (Mixed)
Refrigerate at 2–8°C
Use within 7–14 days
Do not freeze after mixing
Discard if cloudy, discolored, or if particles appear
Important storage note
CJC-1295 NO DAC is short-acting and more delicate once mixed. Keep reconstituted peptide cold and use it within a shorter window than many longer-acting peptides.
Cycle Length & Time Between Cycles
Pulse GH Phase → Break → Reassess IGF-1 + Recovery → Repeat if Needed
Cycle Structure
Cycle Length8–12 weeks
Optional ExtensionUp to 16 weeks
GoalPulsatile GH + IGF-1 support
Time Between Cycles
Break2–4 weeks
Allows GH signaling to reset
Helps maintain responsiveness
Gives time to reassess sleep, recovery, and IGF-1 response
Why cycle?
CJC-1295 NO DAC influences GH pathway signaling. Periodic reassessment helps evaluate whether the intended research goals are being met and whether continued use remains appropriate.
Monitoring During Use
IGF-1 levels, primary marker
Sleep quality
Recovery and soreness
Body composition changes
Water retention or flushing
Benefits
Stimulates natural GH release
Increases IGF-1 levels
Improves recovery and sleep
Supports fat loss and lean mass
Maintains physiologic hormone balance
Potential Side Effects
Injection site irritation
Mild flushing
Headache, rare
Temporary water retention, mild
Possible changes in IGF-1 levels
Potential glucose regulation effects
Stacking Strategies
Short GH Pulse → GHRP Pairing → Recovery + Composition Support
GH Optimization: CJC-1295 NO DAC + Ipamorelin
Fat Loss: CJC-1295 + AOD-9604
Recovery: CJC-1295 + BPC-157
Direct combination evidence is limited
Stacking note
CJC-1295 NO DAC is commonly paired with a GHRP because one compound supports the GHRH side and the other supports ghrelin receptor signaling.
Important Notes
Short half-life requires consistent dosing
Commonly discussed away from meals because nutrient timing may influence GH signaling
Requires functional pituitary response
Acts by stimulating endogenous GH release rather than providing external GH
More timing-sensitive than CJC-1295 DAC

Important Disclaimer

CJC-1295 NO DAC is not FDA-approved. This content is for educational purposes only.

Research & References

Primary Research

CJC-1295 No DAC Guide → Peptide Directory →
Email Post
Similar Links:

Comments

Post a Comment